Clinical Trial Update: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 trial to evaluate the safety, tolerability, and immunogenicity of a multivalent Group B Streptococcus vaccine when administered conco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcus Infections

Drugs mentioned

• Multivalent Group B Streptococcus Vaccine (Group B Streptococcus vaccine (multivalent))
• Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: Pfizer | Conditions: Group B Streptococcus Infections | Phase 2 | Status: COMPLETED | Results posted: 2024-05-24